Insider Selling: Shoulder Innovations (NYSE:SI) Major Shareholder Sells 681 Shares

Posted by Brian Himes on Aug 24th, 2026

Shoulder Innovations, Inc. (NYSE:SI – Get Free Report) major shareholder Healthcare Holding B.V. Gilde sold 681 shares of the company’s stock in a transaction dated Monday, August 24th. The shares were sold at an average price of $22.62, for a total value of $15,404.22. Following the completion of the sale, the insider owned 2,187,110 shares in the company, valued at $49,472,428.20. This trade represents a 0.03% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Major shareholders that own 10% or more of a company’s stock are required to disclose their transactions with the SEC.

Healthcare Holding B.V. Gilde also recently made the following trade(s):

On Friday, August 21st, Healthcare Holding B.V. Gilde sold 20,516 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.61, for a total value of $463,866.76.
On Thursday, August 20th, Healthcare Holding B.V. Gilde sold 3,900 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.60, for a total value of $88,140.00.
On Thursday, August 6th, Healthcare Holding B.V. Gilde sold 2,095 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.60, for a total transaction of $47,347.00.
On Wednesday, August 5th, Healthcare Holding B.V. Gilde sold 7,338 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.64, for a total transaction of $166,132.32.
On Tuesday, August 4th, Healthcare Holding B.V. Gilde sold 99,812 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.77, for a total transaction of $2,272,719.24.
On Monday, August 3rd, Healthcare Holding B.V. Gilde sold 10,751 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.71, for a total transaction of $244,155.21.
On Friday, July 31st, Healthcare Holding B.V. Gilde sold 20,034 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.73, for a total transaction of $455,372.82.
On Thursday, July 30th, Healthcare Holding B.V. Gilde sold 28,245 shares of Shoulder Innovations stock. The stock was sold at an average price of $23.36, for a total value of $659,803.20.

Shoulder Innovations Trading Up 0.8%

Shares of NYSE:SI traded up $0.18 during midday trading on Monday, reaching $22.24. The company’s stock had a trading volume of 75,051 shares, compared to its average volume of 128,345. The firm has a market capitalization of $463.02 million and a price-to-earnings ratio of -11.58. The firm has a 50 day moving average price of $21.03 and a two-hundred day moving average price of $16.60. The company has a debt-to-equity ratio of 0.12, a quick ratio of 8.92 and a current ratio of 10.71. Shoulder Innovations, Inc. has a fifty-two week low of $10.92 and a fifty-two week high of $24.59.

Shoulder Innovations (NYSE:SI – Get Free Report) last posted its quarterly earnings results on Thursday, August 6th. The company reported ($0.49) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.46) by ($0.03). The business had revenue of $17.18 million for the quarter. Shoulder Innovations had a negative return on equity of 23.61% and a negative net margin of 58.33%. As a group, analysts forecast that Shoulder Innovations, Inc. will post -1.9 earnings per share for the current year.

Hedge Funds Weigh In On Shoulder Innovations

Several large investors have recently added to or reduced their stakes in SI. Sectoral Asset Management Inc. boosted its stake in Shoulder Innovations by 14.4% during the 4th quarter. Sectoral Asset Management Inc. now owns 492,435 shares of the company’s stock valued at $7,042,000 after purchasing an additional 62,153 shares during the last quarter. Deerfield Management Company L.P. bought a new position in shares of Shoulder Innovations in the third quarter valued at approximately $6,056,000. Alyeska Investment Group L.P. bought a new stake in Shoulder Innovations during the third quarter worth $5,667,000. Roubaix Capital LLC raised its position in Shoulder Innovations by 61.9% in the 1st quarter. Roubaix Capital LLC now owns 257,121 shares of the company’s stock valued at $3,736,000 after buying an additional 98,305 shares during the last quarter. Finally, Vanguard Group Inc. purchased a new position in Shoulder Innovations during the 3rd quarter worth $1,836,000.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on SI shares. UBS Group upped their price objective on shares of Shoulder Innovations from $27.00 to $28.00 and gave the company a “buy” rating in a report on Monday, August 10th. BTIG Research boosted their target price on Shoulder Innovations from $24.00 to $26.00 and gave the company a “buy” rating in a research report on Friday, August 7th. Weiss Ratings raised Shoulder Innovations from a “sell (d-)” rating to a “sell (d)” rating in a research note on Monday, August 3rd. Finally, Piper Sandler reissued an “overweight” rating and issued a $25.00 price objective (up from $19.00) on shares of Shoulder Innovations in a research note on Friday, August 7th. Six equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, Shoulder Innovations presently has a consensus rating of “Moderate Buy” and a consensus price target of $23.50.

View Our Latest Report on SI

Shoulder Innovations Company Profile

(Get Free Report)

Shoulder Innovations (NYSE:SI) is a medical device company focused on the design, development and commercialization of shoulder implant systems and related surgical instruments for orthopedic surgery. The company’s product portfolio includes modular shoulder prostheses, humeral and glenoid components, and instrumentation kits designed to facilitate both primary and revision shoulder arthroplasty procedures. Emphasizing a patient-centric approach, Shoulder Innovations works to offer implant solutions that aim to restore mobility and reduce post-operative complications.

In addition to its core implant offerings, Shoulder Innovations provides comprehensive clinical support and training programs for surgeons and operating room teams.